NCT07090499 2026-03-19A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT07229313 2026-03-10A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsKivu Bioscience Inc.Phase 1 Recruiting76 enrolled
NCT06747585 2026-03-03A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsAlentis Therapeutics AGPhase 1/2 Recruiting170 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT07109726 2026-02-27A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsTerremoto Biosciences Inc.Phase 1/2 Recruiting205 enrolled
NCT05208762 2026-02-23A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting714 enrolled
NCT04868877 2026-02-19Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationMerus B.V.Phase 1/2 Active not recruiting194 enrolled